WallStreetZenWallStreetZen

NASDAQ: CDXS
Codexis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CDXS

Based on 1 analyst offering 12 month price targets for Codexis Inc

Min Forecast
$11.00+132.56%
Avg Forecast
$11.00+132.56%
Max Forecast
$11.00+132.56%

Should I buy or sell CDXS stock?

Based on 1 analyst offering ratings for Codexis Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CDXS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CDXS as a "Hold". Stocks with a Zen Rating of Hold have beat the market by +7.53%. Learn More

Be the first to know when Wall Street analysts revise their CDXS stock forecasts and price targets.

CDXS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-22

1 of 1

Forecast return on equity

Is CDXS forecast to generate an efficient return?

Company
5.54%
Industry
136.31%
Market
70.63%
CDXS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDXS forecast to generate an efficient return on assets?

Company
2.75%
Industry
22.72%
CDXS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDXS earnings per share forecast

What is CDXS's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.77
Avg 2 year Forecast
-$0.70
Avg 3 year Forecast
-$0.28

CDXS revenue forecast

What is CDXS's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$67.1M+4.16%
Avg 2 year Forecast
$65.3M+1.26%
Avg 3 year Forecast
$97.3M+50.98%
CDXS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDXS revenue growth forecast

How is CDXS forecast to perform vs Biotechnology companies and vs the US market?

Company
8.46%
Industry
34.16%
Market
8.87%
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDXS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDXS$4.73$11.00+132.56%Strong Buy
ENGN$8.65$27.75+220.81%Strong Buy
CTNM$14.69$31.50+114.43%Buy
KRRO$42.58$125.75+195.33%Strong Buy
RVNC$3.82$10.32+170.16%Buy
View Top Biotech Stocks

Codexis Stock Forecast FAQ

Is Codexis Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CDXS) stock is to Strong Buy CDXS stock.

Out of 1 analyst, 1 (100%) are recommending CDXS as a Strong Buy, 0 (0%) are recommending CDXS as a Buy, 0 (0%) are recommending CDXS as a Hold, 0 (0%) are recommending CDXS as a Sell, and 0 (0%) are recommending CDXS as a Strong Sell.

If you're new to stock investing, here's how to buy Codexis stock.

What is CDXS's earnings growth forecast for 2024-2026?

(NASDAQ: CDXS) Codexis's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.33%.

Codexis's earnings in 2024 is -$62,092,000.On average, 5 Wall Street analysts forecast CDXS's earnings for 2024 to be -$62,986,460, with the lowest CDXS earnings forecast at -$72,426,291, and the highest CDXS earnings forecast at -$56,964,499. On average, 4 Wall Street analysts forecast CDXS's earnings for 2025 to be -$56,964,499, with the lowest CDXS earnings forecast at -$61,847,170, and the highest CDXS earnings forecast at -$48,826,713.

In 2026, CDXS is forecast to generate -$22,785,799 in earnings, with the lowest earnings forecast at -$22,785,799 and the highest earnings forecast at -$22,785,799.

What is CDXS's revenue growth forecast for 2024-2026?

(NASDAQ: CDXS) Codexis's forecast annual revenue growth rate of 8.46% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.87%.

Codexis's revenue in 2024 is $64,446,000.On average, 4 Wall Street analysts forecast CDXS's revenue for 2024 to be $5,462,651,273, with the lowest CDXS revenue forecast at $4,964,049,155, and the highest CDXS revenue forecast at $5,803,054,840. On average, 4 Wall Street analysts forecast CDXS's revenue for 2025 to be $5,310,718,817, with the lowest CDXS revenue forecast at $5,208,182,720, and the highest CDXS revenue forecast at $5,444,178,500.

In 2026, CDXS is forecast to generate $7,918,065,292 in revenue, with the lowest revenue forecast at $7,918,065,292 and the highest revenue forecast at $7,918,065,292.

What is CDXS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CDXS) forecast ROA is 2.75%, which is lower than the forecast US Biotechnology industry average of 22.72%.

What is CDXS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CDXS price target, the average CDXS price target is $11.00, with the highest CDXS stock price forecast at $11.00 and the lowest CDXS stock price forecast at $11.00.

The Wall Street analyst predicted that Codexis's share price could reach $11.00 by Nov 22, 2025. The average Codexis stock price prediction forecasts a potential upside of 132.56% from the current CDXS share price of $4.73.

What is CDXS's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: CDXS) Codexis's current Earnings Per Share (EPS) is -$0.87. On average, analysts forecast that CDXS's EPS will be -$0.77 for 2024, with the lowest EPS forecast at -$0.89, and the highest EPS forecast at -$0.70. On average, analysts forecast that CDXS's EPS will be -$0.70 for 2025, with the lowest EPS forecast at -$0.76, and the highest EPS forecast at -$0.60. In 2026, CDXS's EPS is forecast to hit -$0.28 (min: -$0.28, max: -$0.28).

What is CDXS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CDXS) forecast ROE is 5.54%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.